Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Entrada Therapeutics, Inc.

Pharmaceutical Preparations · Boston, MA, United States

  1. PrincipalsDipal DoshiCEOKory James WentworthChief Financial OfficerNatarajan SethuramanPresident, Research & Develop.and 2 more
  2. CompanyEntrada Therapeutics, Inc.Boston, MA, United States
  3. Phone line+1 (857) 305-1825General business
Request a quote

Entrada Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker TRDA) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 5

Chief executive

Natarajan SethuramanPresident, Research & Develop.
Nathan J DowdenPresident & COO

Chair & board

Kush ParmarDirector (Board)

Finance

Kory James WentworthChief Financial Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Nathan J Dowden — President & COO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Natarajan Sethuraman — President, Research & Develop.

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Kory James Wentworth — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers